Closing the Loophole on Hemp-Derived Cannabis Products
- 22 November 2022
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (20) , 2007-2008
Abstract
This Viewpoint discusses a federal policy loophole that allows psychotropic cannabis products to be commercially marketed and sold across the US, even in states where recreational cannabis is not legal.Keywords
This publication has 3 references indexed in Scilit:
- The Hemp Loophole: A Need to Clarify the Legality of Delta-8-THC and Other Hemp-Derived Tetrahydrocannabinol CompoundsAmerican Journal of Public Health, 2021
- The EVALI outbreak and vaping in the COVID-19 eraThe Lancet Respiratory Medicine, 2020
- 5 Things to Know About Delta-8 Tetrahydrocannabinol: Delta-8 THC.